SCHEMBL891810

SCHEMBL891810

CC=COCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1477190 1.00
SCHEMBL3733403 1.00
Ethylene Glycol SCHEMBL8768679 0.89 TSHR (0.32)
SCHEMBL2388236 0.89
SCHEMBL29652095 0.84 HSD17B10 (0.31)
SCHEMBL19859739 0.84 HSD17B10 (0.31)
SCHEMBL6722145 0.83
SCHEMBL10416346 0.83 CA1 (0.30)
SCHEMBL1475674 0.83
SCHEMBL891970 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 393 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116174052-A Method for hydroformylation of propylene or derivatives thereof 中国科学院大连化学物理研究所 2023-05-30 CN claimed
CN-113474913-B Electrochemical device, electronic device, and method for manufacturing electrochemical device 东莞新能源科技有限公司 2022-10-04 CN claimed
CN-112125789-B Preparation method of 1, 8-alkoxy-1, 3,6, 8-tetramethoxy-2, 7-dimethyl-4-octene 万华化学集团股份有限公司 2022-09-20 CN claimed
CN-108299171-B Method for synthesizing methyl heptenone from 2-methyl-3-butene-2-ol 浙江新和成股份有限公司 2021-03-16 CN claimed
CN-111211356-A Lithium secondary battery electrolyte containing solid electrolyte and application thereof 国联汽车动力电池研究院有限责任公司 2020-05-29 CN claimed
US-20070078146-A1 Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma PHARMACIA CORPORATION 2007-04-05 US claimed
US-20060210528-A1 Therapy for tropical diseases ASPIRE BIOTECH, INC. 2006-09-21 US claimed
US-20030143189-A1 Therapy for topical diseases ASPIRE BIOTECH, INC. 2003-07-31 US claimed
WO-2003041686-A2 IMPROVED THERAPY FOR TOPICAL DISEASES MEDLOGIC GLOBAL LIMITED (GB) 2003-05-22 WO claimed
CN-1101801-C Process for synthesizing (E)-2,3-dihalo-2-butylene-1,4-diol and its derivatives GUANGZHOU INST OF CHEMISTRY (CN) 2003-02-19 CN claimed
US-6514977-B1 For treating p38 kinase mediated disorders G.D. SEARLE & COMPANY 2003-02-04 US claimed
US-6423713-B1 Substituted pyrazoles as p38 kinase inhibitors G. D. SEARLE & COMPANY 2002-07-23 US claimed
EP-1144403-A1 SUBSTITUED PYRAZOLES AS P38 KINASE INHIBITORS G.D. SEARLE & CO. (US) 2001-10-17 EP claimed
CN-1271714-A Process for synthesizing (E)-2,3-dihalo-2-butylene-1,4-diol and its derivatives GUANGZHOU INST OF CHEMISTRY (CN) 2000-11-01 CN claimed
WO-2000031063-A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS G.D. SEARLE & CO. (US) 2000-06-02 WO claimed
EP-0286230-B1 PLUG LID FOR A CONTAINER CMB Foodcan plc (GB) 1991-09-11 EP claimed
CN-116659004-B Air conditioner DAIKIN INDUSTRIES, LTD. (JP) 2026-05-26 CN disclosed
EP-4711434-A1 REFRIGERANT CYCLE APPARATUS Daikin Industries, Ltd. (JP) 2026-03-18 EP disclosed
US-4222931-A Stabilizers for synthetic polymers comprising 2,2,6,6-tetramethyl-4-piperidyl ether alcohol or ether, phosphonic acid ester and phenolic antioxidant ARGUS CHEMICAL CORPORATION (US) 1980-09-16 US disclosed
US-4210577-A Stabilizers for synthetic polymers comprising 2,2,6,6-tetramethyl-4-piperidyl carboxylic acid ester, phosphonic acid ester and phenol ARGUS CHEMICAL CORPORATION (US) 1980-07-01 US disclosed